Cannabis Law Report

JUNE 18, 2021

CanMar Recruitment is looking for a Director of Business Development and Partnerships for our client in Montreal, Quebec. As Director of Business Development and Partnerships, you are responsible for leading and accelerating business analysis, sourcing, and deal flow activities. About Our Client. About the Role. Responsibilities.

Business 104

Business Research and Development Advocacy Data 104

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients. The cannabis research problem. What makes a good research study, anyway?

Research and Development 108

Research and Development Data THC Clinical Trials 108

MMJ Recs

OCTOBER 26, 2023

This guide aims to provide an in-depth exploration of medical marijuana laws in the USA, offering insights into the regulations, the legal status of medical marijuana, the differences between federal and state laws, patient rights, dispensary regulations, and much more. Patients can possess up to one ounce of usable marijuana.

Law 98

Law Marijuana Programs Dispensary 98

MMJ Recs

MAY 29, 2024

Pennsylvania, among many states, has embraced this change by implementing a medical marijuana program. This program allows individuals with qualifying medical conditions to access marijuana for therapeutic purposes upon obtaining a medical marijuana card. However, navigating the process of obtaining such a card can seem daunting.

Marijuana 52

Marijuana Programs Patients Conditions 52

MMJ Recs

JUNE 9, 2024

West Virginia’s medical marijuana program was established to provide patients with qualifying medical conditions access to medical cannabis as an alternative treatment option. The program was enacted into law in April 2017 with the passage of the West Virginia Medical Cannabis Act.

Access 52

Access Marijuana Patients Programs 52

Veriheal

MARCH 17, 2021

Fortunately, a group of trailblazers has found a way to impede (delay or prevent) cell growth in Glioblastoma patients. Glioblastoma can therefore be a brain or spinal cancer and is said to have a complex biology, despite decades of dedicated research on the matter. Cannabigerol, or CBG, is a non-intoxicating compound.

Research and Development 109

Research and Development Treatment Cannabinoids THC 109

Cannabis Law Report

JULY 13, 2021

Australia’s Victorian government says Agriculture Victoria Research scientists have developed the world’s most complete medicinal cannabis genomic reference. The organisation has been licensed by the Australian Government to undertake medicinal cannabis research. Hemp Gazette reports. Source: [link].

Medicine 105

Medicine Research and Development Agriculture Strains 105

Cannabis Law Report

MAY 29, 2022

is a Canadian company that researches, develops and grows psilocybin-producing mushrooms and functional mushrooms. Businesses have been recently receiving approval from Health Canada to farm psychedelic mushrooms, make psilocybin and sell the compound to drug-makers, or to doctors to give to patients. Optimi Health Corp.

Research and Development 52

Research and Development Clinical Trials Medicine Access 52

Cannabis Law Report

JANUARY 6, 2022

Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. An especially worrisome development is the efforts of pharmaceutical companies to patent psilocybin products. By Brett Mulligan.

Access 52

Access Patients Research and Development Treatment 52

Cannabis Law Report

AUGUST 3, 2021

Puerto Rico’s Governor has signed legislation into law protecting qualified medical cannabis patients from workplace discrimination. The legislation amends Puerto Rico’s medical marijuana access law so that registered patients are now classified as members of a protected class under the US territory’s employment protection laws.

Patients 105

Patients Law Research and Development Medicine 105

Cannabis Law Report

DECEMBER 26, 2021

In furtherance of its program, the Company filed US Provisional Patent Application No. “Entheon is proud to be making significant strides in its Entheon IQ™ program,” says Timothy Ko, Chief Executive Officer of Entheon. US Provisional Patent Filed. ” In Vivo Toxicity Assays Completed.

Research and Development 52

Research and Development Clinical Trials Treatment Packaging 52

Cannabis Law Report

JUNE 3, 2021

(OTCQB:KOAN), a Wellness Lifestyle cannabis holding company (“Resonate” or “the Company”), announced today it has retained the services of Colleen Quinn, an internationally celebrated clinical aromatherapist, cosmetic chemist, researcher and educator.

Research and Development 87

Research and Development Education Therapy Programs 87

Veriheal

JANUARY 18, 2024

In a revolutionary development that reflects the ever-changing healthcare arena, cannabis nursing has earned official recognition as a specialized field in nursing. Patient education is their primary focus, as they provide knowledgeable guidance on the therapeutic benefits and potential risks of cannabis.

Education 113

Education Therapy Patients Research and Development 113

MMJ Recs

MARCH 16, 2024

Economic Growth and Job Creation of the medical marijuana industry The medical cannabis sector serves as a catalyst for economic expansion and workforce development in regions where it’s legalized. Moreover, ensuring product quality and safety throughout the supply chain is paramount to maintain patient trust and regulatory compliance.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Veriheal

MAY 31, 2022

With a worsening opioid situation and an emerging acceptance of medical cannabis, the Lone Star State has a unique opportunity to develop a successful medical marijuana (MMJ) program for its millions of residents battling chronic pain and numerous other conditions. A 2019 study found that 76% of patients in the U.S.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JUNE 1, 2021

Under the agreement, Native Roots will establish a new tissue culture program at their flagship Denver facility leveraging FRB’s proprietary Clean Stock® platform. At launch, the program will be the first-of-its-kind in Colorado , a differentiating factor in an increasingly competitive market.

Programs 98

Programs Supply Chain Research and Development Hemp 98

Cannabis Law Report

DECEMBER 27, 2019

A Windsor, Ontario-based company Audacia Bioscience is especially focussed on three patented technologies that deliver consumer and patient insights to the industry to close the knowledge gaps in the supply chain. Clinical trials are medical research projects involving human participants.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

Cannabis Law Report

JANUARY 31, 2022

(TSX-V:NUMI, OTC:LKYSF) said that its research facility– Numinus Bioscience– has been included on Health Canada’s list of federally licensed psilocybin producers. This list is available by request to those seeking access to psilocybin through the Special Access Program (SAP), and clinical researchers.

Research and Development 52

Research and Development Clinical Trials Packaging Access 52

MMJ Recs

MARCH 20, 2024

Maryland medical cannabis dispensary services Maryland’s medical cannabis dispensaries offer comprehensive services tailored to meet the needs of registered patients. Trained dispensary staff assist patients in product selection, dosage recommendations, and consumption methods, ensuring personalized care and guidance.

Dispensary 52

Dispensary Programs Access Patients 52

MMJ Recs

FEBRUARY 10, 2024

The journey begins with early debates around the medicinal use of cannabis, leading to the eventual establishment of the state’s medical marijuana program. Scientific research, patient testimonials, and a broader understanding of the plant’s medicinal properties have fundamentally altered public views.

Research and Development 105

Research and Development Marijuana History Legislation 105

Cannabis Law Report

AUGUST 2, 2021

42 of July 9, 2017, also known as the Act to Manage the Study, Development and Research of Cannabis for Innovation, Applicable Standards and Limits (Medicinal Cannabis Act). This amendment expands employment protections to employees who are registered and licensed medical cannabis patients. Act 15 amends Act No.

Patients 98

Patients Law Research and Development Medicine 98

MMJ Recs

NOVEMBER 17, 2023

This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

SpeedWeed

AUGUST 27, 2021

Jushi also expects to bring additional Sèche flower product lines, along with its award-winning flower brand, The Bank, to Ohio medical cannabis patients in the first quarter of 2022. The post Alabama’s Medical Cannabis Program Could Be Delayed appeared first on SpeedWeed. ” View original article.

Programs 52

Programs Banking Research and Development Patients 52

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. So, why did this educational gap develop? Unfortunately, this did not occur.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Puff Puff Post

JANUARY 13, 2020

Now that retailers broadly sell CBD oil, it offers a number of challenges and opportunities to medical researchers. So even when patients use CBD oil with essentially no THC, doctors need to understand a lot more about the complex chemical reactions of cannabinoids and terpenes. Preliminary Research on CBD Oil.

CBD 52

CBD Clinical Trials Research and Development Oil 52

Puff Puff Post

JANUARY 13, 2020

Now that retailers broadly sell CBD oil, it offers a number of challenges and opportunities to medical researchers. So even when patients use CBD oil with essentially no THC, doctors need to understand a lot more about the complex chemical reactions of cannabinoids and terpenes. Preliminary Research on CBD Oil.

CBD 52

CBD Clinical Trials Research and Development Oil 52

United Patients Group

JANUARY 4, 2024

As we move forward into 2024 and beyond, the sector offers diverse paths beyond direct patient care. The growth stems from rising healthcare demand, facility expansion, and the imperative for efficient administration to maintain quality patient care. Adverse drug events (ADEs) affect approximately 7 per 100 hospitalized patients.

Research and Development 52

Research and Development Patients Data Policy 52

SpeedWeed

JUNE 2, 2021

New Hampshire Governor Chris Sununu (R) just signed a bill to expand the list of qualifying conditions for the state’s medical marijuana program. Doctors will also be able to recommend medical pot to minors with ASD, but only if they can confirm that the patient has not responded to conventional medications or treatments.

Conditions 52

Conditions Programs Research and Development Marijuana 52

Cannabis Law Report

JULY 24, 2021

Argel Aguilar-Valles at Carleton University (“Carleton”) Department of Neuroscience by the Accelerate program at Mitacs for research into the anxiolytic potential of TD-010 in preclinical models of chronic anxiety and depression. About BetterLife Pharma. BetterLife Pharma Inc. About Carleton University, Department of Neuroscience.

Research and Development 98

Research and Development Treatment Therapy Media 98

MMJ Recs

SEPTEMBER 19, 2023

However, several common factors contribute to the development of chronic pain. Understanding all of these common causes is crucial for healthcare professionals to develop effective pain management strategies and improve the quality of life for individuals dealing with chronic pain.

Chronic Pain 52

Chronic Pain Patients Treatment Therapy 52

Veriheal

MARCH 15, 2024

Department of Education acknowledges accrediting agencies as part of the criteria for financial aid, accreditation does not automatically mean programs are eligible for this under the Higher Education Act, as stated by a spokesperson to The Repository. They aspire to help students learn about cannabis cultivation, processing, and sales.

Education 57

Education Seed-To-Sale Research and Development Programs 57

Cannabis Law Report

JUNE 8, 2021

OTCQB: SILO) a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, is pleased to announce that it has entered into a Scientific Research Agreement (SRA) with the University of California San Francisco (UCSF). Englewood Cliffs, NJ, June 08, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc.

Patients 92

Patients Research and Development Clinical Trials Chronic Pain 92

Cannabis Law Report

JULY 8, 2021

The study is the first of its kind and will be conducted within Swinburne’s Drugs and Driving Research unit, which is led by Professor Downey. ‘We We are grateful for this grant, and especially for the opportunity to further our research in this space,’ says Professor Downey. ‘It Medicinal Cannabis Research Collaboration (MCRC).

Medicine 98

Medicine Research and Development Safety THC 98

MMJ Recs

DECEMBER 19, 2022

Sometimes, in addition to MMJ treatment, patients need other methods to find some relief. How can I access California’s MMJ program? California has a well-developed MMJ program, with many dispensaries state-wide. Medical marijuana (MMJ) has been proven to help relieve chronic pain, but it’s not the only way. 17607277600.

Chronic Pain 52

Chronic Pain Patients Treatment Research and Development 52

Illinois News Joint

JUNE 16, 2023

Bob Morgan introduced HB1189 , which would have refunded the excess money from the Compassionate Use of Medical Cannabis Fund back to registered medical cannabis patients in Illinois. The $40,000,000 transferred from the Compassionate Use of Medical Cannabis Fund into Cannabis Business Development Fund was increased from $12,000,000.

Research and Development 82

Research and Development Business Patients Cannabis 82